Streetbeat News

Products Services

DRQ

PBR

Dril-Quip, Inc. (NYSE:DRQ) has successfully installed its first 18" x 22" XPAK-De Expandable Liner Hanger in a Santos Basin deepwater pre-salt exploratory well for the Sagitario Location, operated by Petrobras (60%) in partnership with Repsol Sinopec Brasil (20%) and Shell (20%). The technology can accelerate the well construction process, lower operating costs and reduce risks associated with deepwater drilling operations.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 4:02 pm

UPST

Vesta, a mortgage loan origination software provider, has partnered with AI lending marketplace Upstart (NASDAQ:UPST) to launch a new home equity line of credit (HELOC) product. The partnership has resulted in accelerated rollout, improved customer experience, and increased automation in origination. Upstart aims to offer online approval in less than 10 minutes and a closing process of less than five days for the new HELOC product.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 4:01 pm

RUM

Rumble has announced the launch of its Rumble Studio Beta, a platform that allows users to stream to multiple platforms for free, invite guests, see total concurrent viewers, and manage all chats in one dashboard.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:58 pm

BYD

DKNG

MGM

Online sports betting has resumed in Florida after a two-year hiatus, with the only online book available, Hard Rock, owned by the Seminole Tribe, starting to accept online bets. The soft launch is currently only available to select users who were part of Hard Rock's loyalty programs and had accounts with the sportsbook in Florida from Nov. 1 to Nov. 21, 2021. The re-launch comes a week after the Seminole Tribe announced plans to launch in-person sports betting on Dec. 7.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:39 pm

AUPH

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) presented five studies at the annual American College of Rheumatology Convergence 2023, reinforcing the safety and effectiveness of LUPKYNIS® (voclosporin) for the treatment of adult patients with active lupus nephritis. The studies showed that initial therapy with LUPKYNIS® plus standard of care improved safety and demonstrated earlier reductions in proteinuria compared to a conventional regimen. The data also showed an improved safety profile over the first six months of treatment with LUPKYNIS® in combination with low-dose glucocorticoids and lower-dose MMF without compromising efficacy.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:35 pm

PAHC

The FDA has issued a final order to revoke the approved method for detecting residues of carbadox, a drug marketed by Phibro Animal Health Corporation (NASDAQ:PAHC), and proposed to withdraw approval of all new animal drug applications for use of carbadox in medicated swine feed. Phibro has expressed disappointment in the FDA's actions and reiterated its belief in the safety of Mecadox, which has been approved and sold in the US for over 50 years. The company intends to defend its use for customers.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:26 pm

ZFOX

ZeroFox, a cybersecurity company, has teased an announcement to be made on November 13th. The content of the announcement is currently unknown.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:19 pm

JNJ

Janssen Pharmaceutical Companies of Johnson & Johnson announced positive Phase 2 data for Nipocalimab, a treatment for adults with moderate to severe rheumatoid arthritis. The data showed that Nipocalimab reduced levels of circulating IgG antibodies, indicating a key role in driving rheumatoid arthritis disease activity. The results support the progression of Nipocalimab into a combination study. A trial investigating the efficacy and safety of Nipocalimab in combination with an anti-TNFα treatment has recently been initiated.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:18 pm

BNTX

MYNZ

BioNTech SE (NASDAQ: BNTX) posted a surprise earnings with its latest quarterly report but lowered its revenue forecast due to lower demand for Covid vaccines. The company is shifting its focus from COVID-19 to innovative oncology. Meanwhile, Mainz Biomed N.V. (NASDAQ: MYNZ) announced it will be attending one of the largest medical B2B trade fairs in the world and presenting its flagship product, a colorectal cancer detection test.

Portfolio Pulse from Upwallstreet

November 07, 2023 | 3:10 pm

GOOG

GOOGL

GREK

Google has announced the launch of Google News Showcase, a curated online news experience and licensing program, in Greece. This move is expected to enhance Google's presence in the European market.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 3:08 pm